Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease.

@article{Onouchi1995OptimalDA,
  title={Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease.},
  author={Zenshiro Onouchi and Masayoshi Yanagisawa and Toshikazu Hirayama and Nobuyuki Kiyosawa and Hikaru Matsuda and Masahiro Nakashima},
  journal={Acta paediatrica Japonica : Overseas edition},
  year={1995},
  volume={37 1},
  pages={40-6}
}
In an initial study, three groups of patients with Kawasaki disease received either aspirin alone or alkylated immunoglobulin G intravenous preparation (IGIV) 200 mg/kg daily x 3 days + aspirin, or 400 mg/kg alkylated IGIV daily x 3 days + aspirin. In a second study, three groups of patients were treated with either 100, 200 or 400 mg/kg of native IGIV in… CONTINUE READING